New treatment for central vision loss.

(geographic atrophy)

Geographic atrophy overview

Geographic atrophy (GA) is an advanced form of dry AMD that causes retinal cell death and central vision loss. It affects individuals over 60 and has no treatment, but new FDA-approved medications (Syfovre and Izervay) can delay it. The slow, irreversible death of light-sensitive cells in the retina and tissue underlying it causes permanent blind patches and central vision loss. From outside the central retina, it spreads inward, causing loss of central vision but maintaining peripheral vision.

Damage to the retinal pigment epithelium

Symptoms

Fuzzy central vision or spots
Still having trouble reading with glasses
Need better light for details
Reduced color vibrancy
Face recognition issues
Rare: abrupt blind patches, distorted forms, quick vision drops

Causes and Risks

Damage to the retinal pigment epithelium kills photoreceptor cells.
Most common after 60
AMD family history
Lifestyle: Smoking, bad nutrition, and inactivity raise risk.

Diagnosis

OCT scan
Autofluorescence and fundus photography
Dilated eye test
Amsler grid for house monitoring

Treatment Choices

Still no cure; however, medicines can delay progression:
In 2023, the FDA approved Syfovre (pegcetacoplan).
Izervay (avacincaptad pegol)—FDA-approved 2023

The video explains the new treatment for geographic atrophy

Both require 1–2 monthly eye injections.
Possible complications: Infection, inflammation, or wet AMD.
Light and gene therapy are being studied.

Lifestyle and coping methods

Brighter reading/work lighting
Electronic readers or magnifiers
Reading glasses with high power
Mark items boldly.
Social and physical activity maintains quality of life.

New Geographic Atrophy therapies

Two FDA-approved medicines, Syfovre (pegcetacoplan) and Izervay (avacincaptad pegol), delay geographic atrophy (GA) progression by 14–20% but do not restore vision. Further research into gene therapy and complement inhibition may lead to longer-term remedies.

Current FDA-Approved Treatments

Syfovre (pegcetacoplan) passed in 2023.
Eye injections monthly or bimonthly.
Reduces immune-driven retinal damage by targeting complement protein C3.
Slows GA progression by 17-20%.
Risks: inflammation, haemorrhage, high eye pressure, and uncommon retinal vasculitis.

Avacincaptad pegol (Izervay) was approved in 2023.

Monthly shots.
Protein C5 targets the complement.
Slows GA development by 14-18%.
Wet AMD conversion, inflammation, and impaired vision.

Emerging Therapies

Gene therapy
Inserts therapeutic genes into the retina to create protective proteins as a "bio-factory."
This may minimise complement overactivation and retinal cell death.
Clinical studies only; results not yet available outside the study.
Next-generation complement inhibitors
Based on Syfovre/Izervay, newer compounds seek more efficacy with fewer injections.
Continuing long-acting formulation trials.

Studying other methods

Retinal cell replacement with stem cells.
Neuroprotectants slow photoreceptor loss.
Implants and light therapy: vision support experiments.

Risks and Factors

Drugs slow vision loss, not restore it.
These injections are needed monthly or biweekly for life.
Risks include inflammation, hemorrhage, wet AMD conversion, and uncommon retinal vasculitis.
Patient decision-making: evaluate minor benefits against dangers and treatment burden.

Avoiding Geographic Atrophy

You can reduce your risk of geographic atrophy (GA) and slow its progression by quitting smoking, eating an antioxidant-rich diet, protecting your eyes from UV light, and managing chronic conditions like diabetes and hypertension. Regular eye exams are the best prevention.

Important Prevention Methods

Give up smoking
Smoking is the biggest modifiable risk. Stopping lowers retinal oxidative stress.

Dietary health

Mediterranean diets include leafy greens, fruits, fish, nuts, and omega-3s.
Lutein, zeaxanthin, vitamin E, zinc, and copper AREDS2 supplements may decrease AMD progression.

Managing chronic conditions

Manage diabetes, hypertension, cholesterol, and obesity.
This condition increases retinal stress and oxidative damage.

Protect eyes from UV

Outdoors, wear UV or yellow sunglasses.
Reduces cumulative retinal light damage.

A regular eye exam

Essential for AMD/GA early detection.
Recommended every 1–2 years after 60.

Unchangeable Risk Factors

Age: Most cases occur after 60.
AMD risk increases with family history.
Caucasians and light-eyed individuals are more sensitive.

Non-modifiable vs. lifestyle risks

Modifiable factors include smoking, poor diet, obesity, uncontrolled diabetes, and UV exposure.
Stop smoking, eat antioxidant-rich foods, regulate health, and wear sunglasses.
Non-modifiable genetics, ethnicity, eye colour, and age. Regular checks, early detection

Managing Geographic Atrophy treatment side effects

Regular monitoring, prompt reporting of new symptoms, and supportive care like lubricating drops, infection prevention, and ophthalmologist follow-up after each injection are needed to manage geographic atrophy (GA) side effects like Syfovre (pegcetacoplan) and Izervay (avacincaptad pegol). Redness, floaters, and discomfort are common side effects, but infection or wet AMD requires immediate medical attention.

Typical Side Effects

Injection site redness or soreness is usually mild and transient.
Small dark patches in eyesight, called floaters, usually go away.
Follow-up visits measure eye pressure.
Extreme pain, vision loss, pus, and swelling are signs of endophthalmitis, a rare but serious infection.
Wet AMD conversion leads to abrupt visual alterations due to aberrant blood vessel development.
Intraocular inflammation or vasculitis requires rapid medical attention.

Managerial Strategies

Call your ophthalmologist immediately if you experience sudden vision loss, significant pain, or swelling.
Lubricating eye drops: Reduce injection-related irritation and dryness.
Cold compresses: Reduce injection-site redness and edema.
Stick to hygiene: Avoid touching or rubbing your eyes after injections to avoid infection.
Regular monitoring: Assess Amsler grids monthly for blind spots and distortion.
Follow-up exams: Crucial for detecting issues like wet AMD conversion.

Risks and Urgent Care When

If you experience: Seek medical treatment immediately.
Serious eyesight loss suddenly
Extreme eye discomfort or edema
Bright spots or new floaters
Infection signs (pus, discharge, fever)

Geographic Atrophy Prevention Daily Checklist

The following daily routine checklist can help prevent and slow geographic atrophy. Consider it a lifestyle guide for eye and health protection.

Morning

A healthy breakfast: Leaves, berries, and omega-3s (flaxseed or salmon)
Your doctor may prescribe AREDS2 supplements.
Before going outside, wear UV sunglasses.

Midday

Lunch balance: Whole grains, lean protein, and colorful vegetables.
Hydration check: Stay hydrated for eye and body health.
A short walk or workout boosts circulation and decreases oxidative stress.

Evening

For reading or detail work, choose bright, warm lighting.
Amsler grid self-check: Weekly blind spot and distortion monitoring.
Screen breaks: Every 20 minutes, look 20 feet away for 20 seconds.

Night

Light dinner: Choose antioxidant-rich greens, kale, and carrots.
Sleep hygiene: Get 7–8 hours of good sleep to restore retinas.
Before bed, avoid smoking and alcohol, which cause oxidative stress.

Weekly/Monthly Habits

Weekly Amsler grid exam. Detect vision changes early
Monitor glucose and blood pressure monthly. Managing chronic conditions
An ophthalmologist checks every 6–12 months for early AMD/GA detection.
Keep weight in check and quit smoking. Reduce modifiable risks

Your visual daily calendar for Geographic Atrophy prevention, an hour-by-hour routine with icons and color-coded morning, afternoon, evening, and night parts for easy following and remembering.

This planner emphasises:

Morning: Healthy breakfast, vitamins, sunglasses
Balanced meals, exercise, hydration
Evening: Amsler grid exam, right illumination, 20-20-20 rule
Night: Light dinner, sleep hygiene, no smoking/drinking
At the bottom, it reminds you to have regular eye exams, which are essential for prevention.

Conclusion

Geographic atrophy (GA) is a slow but deadly illness that cannot be reversed, but early discovery and regular preventive therapy can help. An organised daily routine—nutrient-rich meals, UV protection, regular exercise, and eye monitoring—protects your eyesight and health.

Your easy, encouraging graphic daily planner helps you maintain these behaviors. It should be combined with frequent eye exams and open discussion with your ophthalmologist to detect abnormalities early and adjust treatment.

Discipline and awareness—small everyday efforts that protect your sight for years—are the keys to prevention.

Vaalga Endrum